Key Market Indicators
Sales of diagnostic reagents in Italy are expected to reach €327 million by 2026, an increase of 3.1% on average year on year from €268 million in 2021. Since 2001, the Italian market has grown by 8% year on year. In 2021, Finland held the top spot in this ranking, with €268 million. The United Kingdom, Ireland and Sweden came in second, third and fourth, respectively. Italian exports of diagnostic reagents are projected to reach $550 million by 2026, a year-on-year compound annual growth rate of 1.2% from $511 million in 2021. Since 1999, the Italian supply has jumped by 4.7% year on year. In 2021, Canada topped the ranking, with $511 million. Germany, the Netherlands and the United Kingdom came in second, third and fourth, respectively. Italian imports of diagnostic reagents are predicted to reach $1.34 billion by 2026, a year-on-year compound annual growth rate of 1% from $1.26 billion in 2021. Since 1999, the Italian demand has increased by 4.5% year on year. In 2021, France led the ranking, with $1.26 billion. Germany, China and the Netherlands came in second, third and fourth, respectively.
Italy In Vitro Diagnostics Market Data and Forecasts
How much will Italy In Vitro Diagnostics Market grow to 2026?
More in In Vitro Diagnostics Industry for 2028Improve your Knowledge with the latest Indicators and Trends
-
Exploring Trends and Strategies in the Global Automated Microbiology Market
The global market for automated microbiology technology, equipment and consumables is experiencing significant growth, largely driven by the increasing demand for advanced diagnostic techniques. New technologies such as next-generation sequencing and high-throughput systems are offering enhanced accuracy, efficiency, and sensitivity in bacterial identification and susceptibility testing. The rise in infectious...
Discover more insights -
Medical Diagnostics: Unveiling Trends in Hemostasis, Virology, and Bacteriology Testing
The hemostasis diagnostics market segment has experienced steady growth due to the increasing prevalence of conditions causing prolonged bleeding disorders such as hemophilia and Von Willebrand Disease (VWD). Despite facing challenges in terms of high costs and complex procedures, advancements in automation and growing demands for precise results have encouraged...
Discover more insights -
Hematology and Flow Cytometry Markets: Unraveling Cutting-edge Technologies and Strategic Competitions
The medical diagnostic sector has witnessed remarkable progress by leveraging advancements in hematology and flow cytometry technology. Research continues to expand, fostering better, more precise systems, which could yield valuable insights into blood and immune disorders. Novel markers and probes utilized in flow cytometry have enhanced our understanding of cellular...
Discover more insights -
Immunodiagnostics: Unveiling Opportunities and Strategies in Therapeutic Drug Monitoring and Tumor Markers Sectors
Both therapeutic drug monitoring (TDM) and tumor markers form integral parts of the burgeoning immunodiagnostics domain. TDM's main function is to regulate drug dosage levels to achieve optimum therapeutic effect with minimal toxicity. Tumor markers, on the other hand, are biological substances indicative of the presence of cancer cells in...
Discover more insights -
Hospital Microbiology Testing: Uncovering Growth Strategies and Opportunities
The realm of clinical microbiology in Germany has seen significant advancements in recent years. The adoption of automated systems has bolstered laboratory efficiency and diagnostics accuracy, reducing turnaround times for infection detection. An emphasis on multidrug resistance testing due to heightened global concerns has also propelled innovations in this segment,...
Discover more insights